128 related articles for article (PubMed ID: 33332774)
1. Identification of Phenazine-Based MEMO1 Small-Molecule Inhibitors: Virtual Screening, Fluorescence Polarization Validation, and Inhibition of Breast Cancer Migration.
Labrecque CL; Hilton CN; Airas J; Blake A; Rubenstein KJ; Parish CA; Pollock JA
ChemMedChem; 2021 Apr; 16(7):1163-1171. PubMed ID: 33332774
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.
Zhao R; Fu L; Yuan Z; Liu Y; Zhang K; Chen Y; Wang L; Sun D; Chen L; Liu B; Zhang L
Eur J Med Chem; 2021 Jan; 210():113088. PubMed ID: 33316691
[TBL] [Abstract][Full Text] [Related]
3. Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines.
Liao J; Wang L; Wu Z; Wang Z; Chen J; Zhong Y; Jiang F; Lu Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1158-1163. PubMed ID: 31179772
[TBL] [Abstract][Full Text] [Related]
4. Small Molecular Leads Differentially Active Against HER2 Positive and Triple Negative Breast Cancer Cell Lines.
Badran A; Atia-Tul-Wahab ; Fayyaz S; Baydoun E; Choudhary MI
Med Chem; 2019; 15(7):738-742. PubMed ID: 30398120
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative activity of novel polynuclear heterocyclic compounds derived from 2,3-diaminophenazine.
Mahran AM; Ragab SSh; Hashem AI; Ali MM; Nada AA
Eur J Med Chem; 2015 Jan; 90():568-76. PubMed ID: 25497130
[TBL] [Abstract][Full Text] [Related]
6. Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer.
Lu J; Zhou K; Yin X; Xu H; Ma B
Comput Biol Chem; 2019 Feb; 78():290-296. PubMed ID: 30605854
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
[TBL] [Abstract][Full Text] [Related]
8. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors.
Lin TE; Sung LC; Chao MW; Li M; Zheng JH; Sung TY; Hsieh JH; Yang CR; Lee HY; Cho EC; Hsu KC
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):226-235. PubMed ID: 34894949
[TBL] [Abstract][Full Text] [Related]
10. Analysis of MEMO1 Binding Specificity for ErbB2 Using Fluorescence Polarization and Molecular Dynamics Simulations.
Newkirk ML; Rubenstein KJ; Kim JY; Labrecque CL; Airas J; Taylor CA; Evans HD; McKoy Q; Parish CA; Pollock JA
Biochemistry; 2018 Aug; 57(34):5169-5181. PubMed ID: 30067338
[TBL] [Abstract][Full Text] [Related]
11. Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1).
Beekman AM; O'Connell MA; Howell LA
ChemMedChem; 2016 Apr; 11(8):840-4. PubMed ID: 26616140
[TBL] [Abstract][Full Text] [Related]
12. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
Huang Q; Zhong Y; Li B; Ouyang S; Deng L; Mo J; Shi S; Lv N; Wu R; Liu P; Hu W; Zhang X; Wang Y
Eur J Med Chem; 2021 Oct; 221():113525. PubMed ID: 34000483
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluations of diverse Michael acceptor-based phenazine hybrid molecules as TrxR1 inhibitors.
Zhong Y; Liu J; Cheng X; Zhang H; Zhang C; Xia Z; Wu Z; Zhang L; Zheng Y; Gao Z; Jiang Z; Wang Z; Huang D; Lu Y; Jiang F
Bioorg Chem; 2021 Apr; 109():104736. PubMed ID: 33640630
[TBL] [Abstract][Full Text] [Related]
14. In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents.
Debnath S; Kanakaraju M; Islam M; Yeeravalli R; Sen D; Das A
Comput Biol Chem; 2019 Dec; 83():107156. PubMed ID: 31710991
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design of HSPA5 inhibitors: from peptide to small molecule inhibitors.
Huang M; Li Z; Li D; Walker S; Greenan C; Kennedy R
Bioorg Med Chem Lett; 2013 May; 23(10):3044-50. PubMed ID: 23562057
[TBL] [Abstract][Full Text] [Related]
16. Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.
Wang L; Li L; Zhou ZH; Jiang ZY; You QD; Xu XL
Eur J Med Chem; 2017 Aug; 136():63-73. PubMed ID: 28482218
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial AZT derivative regulates metastasis of breast cancer cells.
Chirumarry S; Soung NK; Han J; Kim EY; Ryu EK; Lee YH; Shin SY; Gunasekaran P; Bang JK
Eur J Med Chem; 2020 May; 193():112233. PubMed ID: 32199136
[TBL] [Abstract][Full Text] [Related]
18. An Integrated in silico Approach and in vitro Study for the Discovery of Small-Molecule USP7 Inhibitors as Potential Cancer Therapies.
Kanan D; Kanan T; Dogan B; Orhan MD; Avsar T; Durdagi S
ChemMedChem; 2021 Feb; 16(3):555-567. PubMed ID: 33063944
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships for analogues of the phenazine-based dual topoisomerase I/II inhibitor XR11576.
Wang S; Miller W; Milton J; Vicker N; Stewart A; Charlton P; Mistry P; Hardick D; Denny WA
Bioorg Med Chem Lett; 2002 Feb; 12(3):415-8. PubMed ID: 11814810
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel benzo[a]pyridazino[3,4-c]phenazine derivatives.
Le-Nhat-Thuy G; Dang Thi TA; Nguyen Thi QG; Hoang Thi P; Nguyen TA; Nguyen HT; Nguyen Thi TH; Nguyen HS; Nguyen TV
Bioorg Med Chem Lett; 2021 Jul; 43():128054. PubMed ID: 33895275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
